Newsletter

Generalized Myasthenia Gravis
A chronic autoimmune neuromuscular disease with almost 55% of the cases diagnosed in the US in the 7MM, gMG has managed to garner the attention of several pharma companies
Generalized Myasthenia Gravis

More Whitepapers / Newsletters

Retinitis pigmentosa Newsletter
Retinitis pigmentosa

Retinitis pigmentosa is a gradual deterioration of the ability of eyes to see. The defect in the eye is inflicted upon the light-sensitive tissue...

The Ophthalmic drug delivery therapeutics for retinal disorders Whitepaper
The Ophthalmic drug delivery therapeutics for retinal disorders Whitepaper

Delivery of therapeutics to the human eye is among the most interesting endeavours a...

Paroxysmal Nocturnal Hemoglobinuria Whitepaper
Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare acquired disease that leads to the destruction of red blood cells...

Hereditary ATTR (hATTR) Amyloidosis Newsletter
Hereditary ATTR (hATTR) Amyloidosis

Transthyretin Amyloidosis (ATTR) is a progressive build-up of abnormal deposits of amyloid protein in the body's organs...

Focal Segmental Glomerulosclerosis Newsletter
Focal Segmental Glomerulosclerosis

A rare glomerular kidney-scarring disease, Focal Segmental Glomerulosclerosis (FSGS) is a disease with prevalent cases...